Webhealth Logo

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Webhealth Logo
  • Home
  • HealthCare Pros
    • US Medical Doctor Directory
    • US Nurse Directory
    • Sign Up or Log In
  • HealthCare Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Videos
  • Solutions
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Adenocarcinoma of the Appendix - 25 Studies Found

Status Study
Recruiting Study Name: Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
Condition: Ovarian Cancer Ovarian Carcinoma Fallopian Tube Cancer
Date: 2017-05-03
Interventions: Procedure: Uterine lavage Uter
Recruiting Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla
Date: 2016-07-13
Interventions: Procedure: Biospecimen Collection
Not yet recruiting Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas
Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC)
Date: 2016-04-22
Interventions: Drug: Birinapant Birinapant -
Recruiting Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
Condition: HER2/Neu+ Uterine Serous Carcinoma
Date: 2015-07-02
Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28
Recruiting Study Name: Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Condition: Cancer
Date: 2015-04-14
Interventions: Drug: systemic chemotherapy twelve months of 5-FU or capecitabine with bevacizumab starting 4-8 weeks af
Active, not recruiting Study Name: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condition: Advanced GI Cancer
Date: 2014-10-15
Interventions: Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14
Recruiting Study Name: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
Condition: Noninvasive Mucinous Cystadenocarcinoma of Ovary
Date: 2014-04-22
Interventions: Other: A sampling of blood A sampling of blood de 14 ml
Recruiting Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear
Date: 2014-03-28
Interventions: Drug: Gemcitabine Hydrochloride
Recruiting Study Name: Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Condition: Gastrointestinal Neoplasms
Date: 2013-09-12
Interventions: Behavioral: Questionnaire Completion of 3 questionnaires a
Active, not recruiting Study Name: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Condition: Mucinous Adenocarcinoma of the Colon Muci
Date: 2012-07-25
Interventions: Biological: aflibercept 4 mg/k
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.